Notably, ASS1 deficiency has been associated with clinically aggressive states of nasopharyngeal carcinoma and pancreatic ductal adenocarcinoma (Lan et al., 2014; Liu et al., 2017). This evidence concerns the gene ASS1 and nasopharyngeal carcinoma.